Company Earnings Update 3 minutesRegister for Free AccessCVS Health (CVS) 2Q17 Results: Beats Consensus, Narrows Guidance Range Coresight Research August 9, 2017 Executive Summary CVS Health reported 2Q17 adjusted EPS of $1.33, up 0.7% year over year and beating the $1.31 consensus estimate. Revenues were $45.7 billion, up 4.5% year over year, beating the $45.35 billion consensus estimate. Pharmacy Services was the fastest-growing segment, with revenues up 9.5% year over year, to $32.3 billion. Revenues in the Retail/LTC (Long-Term Care) segment declined by 2.2%. The company narrowed its 2017 adjusted EPS guidance range upward,to $5.83–$5.93 from $5.77–$5.93. Already a subscriber? Log in You are currently viewing a preview of this report. Please select an access option to view the full report. Hide Options - Show Options + Get unlimited access to all our research with one of our subscription plans. View Subscription Plans or Contact us to purchase this report. Contact us ✕ This document was generated for Other research you may be interested in: Weekly US and UK Store Openings and Closures Tracker 2023, Week 26: Walgreens Boots Alliance Drives Closures on Both Sides of the AtlanticOctober 2023 China Retail Sales: Year-over-Year Growth Rate Continues To ImproveRetail Around the World: Singles’ Day 2023—Coresight Research ObservationsBed Bath & Beyond: What Went Wrong?